首页> 外文期刊>Journal of Global Health >Treatment delays in oncology patients during COVID-19 pandemic: A perspective
【24h】

Treatment delays in oncology patients during COVID-19 pandemic: A perspective

机译:Covid-19大流行期间肿瘤学患者的治疗延迟:一个观点

获取原文
           

摘要

Ever since the emergence of novel coronavirus disease 2019 (COVID-19) in Wuhan, China, it has impacted mankind globally. WHO declared it a public health emergency since March 11, 2020 [1]. A major effect of it has been seen in the health sector worldwide, due to the unpreparedness for such an event. Lockdown and social distancing, though necessary non-pharmacological measures to flatten the transmission curve, have further aggravated the interruption of health care services to the needy. Worse survival has been reported in oncology patients during the COVID crisis, due to their compromised immunity, which could be disease or anticancer treatment-related. As a considerable fraction of patients visiting the health care institute are oncology patients, interruption of health care services during the crisis might delay treatment in these patients.
机译:自2019年新型冠状病毒疾病的出现以来(Covid-19)在中国武汉,它在全球影响人类。自2020年3月11日以来,谁宣布了公共卫生紧急情况[1]。由于这种事件的毫无准备,它在全球卫生部门已经看到了它的主要影响。锁定和社会疏散,虽然必要的非药理学措施来平整传输曲线,但进一步加剧了对需要的医疗保健服务的中断。由于其受损免疫危害,在Covid危机期间,在肿瘤患者中报道了更糟糕的存活率,这可能是疾病或抗癌治疗有关的疾病。作为访问医疗院的患者的相当大部分,是肿瘤学患者,危机期间的医疗保健服务的中断可能会延迟这些患者的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号